Ocular surface and anterior chamber lesions in daily practice
Please note this is an evening webinar and the start time is 7.30PM BST.
We are currently delivering our webinars with speakers and the technical support team working remotely from each other. We aim to maintain our usual high standard of delivery but thank you for your understanding in the event of technical hitches.
Ocular surface and anterior chamber malignancies are rare but potentially serious diseases. Initial signs and symptoms may be insignificant. Therefore, the correct diagnosis and appropriate treatment are often delayed. This webinar, funded by DOCET and managed by the College of Optometrists, will provide an overview of the most important malignancies and pre-malignancies of the ocular surface and anterior chamber and how to spot them, provide an update on the latest classification and terminology of such lesions, and review the current management recommendations. Areas to be covered include conjunctival tumours and anterior chamber lesions such as iris cysts, naevus and melanomas and ciliary body melanoma.
You will be able to claim one interactive CET point after attending this live session.
1.2.4. To be able to effectively explain and advise patients presenting with suspicious anterior eye lesions about their ocular condition and any follow-up or referral required.
6. Ocular Disease
6.1.5. Is able to differentially diagnose common lesions of the conjunctiva and anterior chamber and understands which can be monitored in practice and when referral is required.
6.1.11. To understand the treatment and management of conjunctival and anterior chamber malignancies.
2. Standards of Practice
2.6.2. To be able to recognise when a patient needs to be referred with anterior eye lesions that are suspicious of being malignant
Terms and conditions:
• To attend this webinar you must be a GOC registered optometrist.
• To obtain your interactive CET point you must ensure the following standards are met, you must:
- have a minimum attendance of 50 minutes
- complete a minimum of 4 of the 6 polls.
CET does not apply to students and pre-registration trainees.
Please note, when booking, if you are not a College member, enter your email address or GOC number and click FORGOTTEN on the Login page to create a password. Contact email@example.com for help.
What optometrists say about DOCET:
‘I liked the way the speaker always referred to us the optometrists and saw things from our point of view with clear practical advice on how we can manage lesions better and when to refer.’
Attendee, DOCET Webinar on Choroidal and retinal lesions in everyday practice
Prof Heinrich Heimann
Heinrich Heimann is a Consultant Ophthalmic Surgeon at the Royal Liverpool University Hospital. He completed his Ophthalmology training at the University Hospital Benjamin Franklin of the Free University in Berlin, Germany, in 1998. Since 2005, he holds a Consultant post at St Paul´s Eye Unit at the Royal Liverpool University Hospital with the subspecialties Surgical and Medical Retina and Ocular Oncology. In 2013, Mr Heimann took over as the Clinical Lead of the Liverpool Ocular Oncology Unit, one of the four Highly Specialised NHS Services for Adult Ocular Oncology in the UK.
Following a MD in corneal surgery in 1995, Mr Heimann completed the German Habilitation degree coordinating a prospective multicentre study on retinal detachment surgery in 2006; he was awarded the title of a Clinical Professor at the Free University Berlin in 2010, and then became Honorary Professor at the Liverpool University in 2015. Heinrich Heimann worked as an elected Executive Board Member of the German Retina society between 2008-16. He currently is an Associate Editor of “Ophthalmologica” and the “Journal of Vitreoretinal Diseases” and section editor for "Ocular Oncology in Eye”.
Mr Heimann has published more than 160 publications in peer-reviewed journals, mostly in the subspecialties of Vitreoretinal Surgery and Ocular Oncology. He has written more than 40 book chapters and co-edited five books on retinal imaging and vitreoretinal surgery.